Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatment.
Smith N, Rodero MP, Bekaddour N, Bondet V, Ruiz-Blanco YB, Harms M, Mayer B, Bader-Meunier B, Quartier P, Bodemer C, Baudouin V, Dieudonné Y, Kirchhoff F, Sanchez Garcia E, Charbit B, Leboulanger N, Jahrsdörfer B, Richard Y, Korganow AS, Münch J, Nisole S, Duffy D, Herbeuval JP. Smith N, et al. Sci Adv. 2019 Jul 10;5(7):eaav9019. doi: 10.1126/sciadv.aav9019. eCollection 2019 Jul. Sci Adv. 2019. PMID: 31309143 Free PMC article.
[Childhood-onset systemic lupus erythematosus].
Bader-Meunier B, Quartier P, Deschênes G, Cochat P, Haddad E, Koné-Paut I, Leblanc T, Prieur AM, Salomon R, Bodemer C, Lévy M; Group française d'étude du lupus érythémateux disséminé de l'enfant. Bader-Meunier B, et al. Arch Pediatr. 2003 Feb;10(2):147-57. doi: 10.1016/s0929-693x(03)00313-0. Arch Pediatr. 2003. PMID: 12829358 Review. French.
[Disseminated lupus erythematosus in children: guidelines about investigations during the initial evaluation and follow-up].
Bader-Meunier B, Haddad E, Niaudet P, Loirat C, Leblanc T, Amoura Z, Bodemer C, Cochat P, Deschênes G, Koné-Paut I, Lévy M, Prieur AM, Quartier P, Ranchin B, Salomon R, Piette JC; Groupe d'étude du lupus érythémateux systémique à début pédiatrique. Bader-Meunier B, et al. Arch Pediatr. 2004 Aug;11(8):941-4. doi: 10.1016/j.arcped.2004.01.027. Arch Pediatr. 2004. PMID: 15288087 French.
Prognosis of lupus membranous nephropathy in children.
Nathanson S, Salomon R, Ranchin B, Macher MA, Lavocat MP, Krier MJ, Baudouin V, Azéma C, Bader-Meunier B, Deschênes G. Nathanson S, et al. Pediatr Nephrol. 2006 Aug;21(8):1113-6. doi: 10.1007/s00467-006-0129-z. Epub 2006 Jun 30. Pediatr Nephrol. 2006. PMID: 16810516
Causes of death in pediatric systemic lupus erythematosus.
Klein A, Cimaz R, Quartier P, Decramer S, Niaudet P, Baudouin V, Belot A, Bader-Meunier B. Klein A, et al. Clin Exp Rheumatol. 2009 May-Jun;27(3):538-9. Clin Exp Rheumatol. 2009. PMID: 19604455 Free article. No abstract available.
[New treatments for idiopathic juvenile arthritis].
Bader-Meunier B, Quartier P. Bader-Meunier B, et al. Arch Pediatr. 2009 Dec;16(12):1607-11. doi: 10.1016/j.arcped.2009.07.020. Epub 2009 Nov 5. Arch Pediatr. 2009. PMID: 19896351 French.
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registry.
Bader-Meunier B, Decaluwe H, Barnerias C, Gherardi R, Quartier P, Faye A, Guigonis V, Pagnier A, Brochard K, Sibilia J, Gottenberg JE, Bodemer C; Club Rhumatismes et Inflammation. Bader-Meunier B, et al. J Rheumatol. 2011 Jul;38(7):1436-40. doi: 10.3899/jrheum.101321. Epub 2011 Jun 15. J Rheumatol. 2011. PMID: 21677003
297 results